Lorazepam — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Anxiety Disorder

• Alprazolam
• Buspirone
• Duloxetine
• Escitalopram
• Paroxetine
• Sertraline
• Venlafaxine

Also listed for Generalized Anxiety Disorder

• Gabapentin

Other medications in Mental Health

• Loxapine
• Lumateperone
• Lurasidone
• Maprotiline
• Methylphenidate
• Mirtazapine
• Molindone
• Naltrexone

About Lorazepam

Lorazepam is a widely prescribed medication known for its effectiveness in managing anxiety and related conditions. For many, the cost of essential prescriptions can be a significant burden. TheDrugClub is here to help, offering members incredible savings, including $0 co-pays and free home delivery on medications like lorazepam, making vital treatment accessible and affordable.

What is Lorazepam and What Does It Treat?

Lorazepam, commonly known by its brand name Ativan, is a benzodiazepine medication prescribed to help manage a variety of conditions. Its primary use is in treating anxiety disorders, providing a calming effect that can significantly reduce feelings of worry, nervousness, and tension. Beyond general anxiety, it's also effective for short-term relief of insomnia, especially when sleep difficulties are linked to anxiety. In a hospital setting, lorazepam plays a crucial role in treating acute seizures and managing symptoms

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Lorazepam is approved for (FDA label)

Lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

Source: Read the full FDA label on DailyMed. Label effective date: September 10, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Lorazepam (FDA label)

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation (see WARNINGS and PRECAUTIONS ). The use of benzodiazepines, including lorazepam tablets, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing lorazepam and throughout treatment, assess each patient’s risk for abuse, misuse, and addiction (see WARNINGS ). The continued use of benzodiazepines, including lorazepam tablets, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of lorazepam tablets after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue lorazepam tablets or reduce the dosage ( DOSAGE AND ADMINISTRATION and WARNINGS ).

Source: FDA prescribing information (DailyMed). Set ID: c0810422-b732-4c04-97d8-c1521c401ef4. SPL document ID: 5b232af4-dc8b-8ee2-e063-6394a90a26ab. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Lorazepam (FDA label)

Most adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 patients treated for anxiety, the most frequent adverse reaction to lorazepam was sedation (15.9%), followed by dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age.

Source: FDA prescribing information (DailyMed). Set ID: c0810422-b732-4c04-97d8-c1521c401ef4. SPL document ID: 5b232af4-dc8b-8ee2-e063-6394a90a26ab. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Lorazepam (FDA label)

Lorazepam is contraindicated in patients with: hypersensitivity to benzodiazepines or to any components of the formulation acute narrow-angle glaucoma.

Source: FDA prescribing information (DailyMed). Set ID: c0810422-b732-4c04-97d8-c1521c401ef4. SPL document ID: 5b232af4-dc8b-8ee2-e063-6394a90a26ab. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Lorazepam (FDA label)

The concomitant use of benzodiazepines and opioids increases the risk of respiratory depression because of actions at different receptor sites in the CNS that control respiration. Benzodiazepines interact at GABAA sites and opioids interact primarily at mu receptors. When benzodiazepines and opioids are combined, the potential for benzodiazepines to significantly worsen opioid-related respiratory depression exists. Limit dosage and duration of concomitant use of benzodiazepines and opioids, and monitor patients closely for respiratory depression and sedation. The benzodiazepines, including lorazepam, produce increased CNS-depressant effects when administered with other CNS depressants such as alcohol, barbiturates, antipsychotics, sedative/hypnotics, anxiolytics, antidepressants, narcotic analgesics, sedative antihistamines, anticonvulsants, and anesthetics. Concomitant use of clozapine and lorazepam may produce marked sedation, excessive salivation, hypotension, ataxia, delirium, and respiratory arrest. Concurrent administration of lorazepam with valproate results in increased plasma concentrations and reduced clearance of lorazepam. Lorazepam dosage should be reduced to approximately 50% when coadministered with valproate.

Source: FDA prescribing information (DailyMed). Set ID: c0810422-b732-4c04-97d8-c1521c401ef4. SPL document ID: 5b232af4-dc8b-8ee2-e063-6394a90a26ab. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.